Skip to content

Efficacy of irrigation with oil of Banafsha versus Fluoxetine in patients of depression after stroke.

Efficacy of Nutool with Roghan-i-Banafsha versus Fluoxetine in Post Stroke Depression - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069580
Enrollment
44
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F39- Unspecified mood [affective] disorder

Interventions

Intervention1: Nutool (Irrigation) with Banafsha oil: In test group,1 liter of Roghan-i-Banafsha will be poured by Nutool pot in a constant stream from a height of approximately 65cm over forehead of

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Presence of depression with Hamilton score more than 15 2 Age in between 18 to 70 years 3 Either gender 4 Patients having single ischemic or hemorrhagic stroke documented by cerebral CT scanning or MRI before enrolment 5 Patients having history of stroke less than 3months 6 Willing and able to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1 Age below 18 and above 70 years 2 Pregnant and lactating mothers 3 Uncontrolled Co-morbidities such as Hypertension, Diabetes Mellitus, Renal and Hepatic diseases 4 Severe Aphasia, Epilepsy and Chronic alcoholism 5 Concomitant skin disease at the application site 6 History of using MAO(Monoamine oxidase) inhibitors within two weeks

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale (HDRS17) scoreTimepoint: At baseline, 2 weeks, 4 weeks

Secondary

MeasureTime frame
SF-36 for Quality of lifeTimepoint: At baseline, 2 weeks, 4 weeks

Countries

India

Contacts

Public ContactProf Abdul Nasir Ansari

National Institute of Unani Medicine

abdulnasiransari@gmail.com9379165162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026